Stock Based Compensation

9 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Based Compensation

Note 4. Stock Based Compensation

The Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans.

Total stock-based compensation expense recognized in the statements of comprehensive income for the three-month periods ended March 31, 2017 and 2016 was $40,245 and $22,284, respectively, before income taxes. The related total deferred tax benefits were approximately $3,769 and $1,765 for the same periods. Total stock-based compensation expense recognized in the statements of comprehensive income for the nine-month periods ended March 31, 2017 and 2016, was $93,293 and $74,533, respectively. The related total deferred tax benefit was approximately $7,893 and $6,206 for the same periods. ASC 718 requires the tax benefits resulting from tax deductions in excess of the compensation cost recognized for those options to be classified and reported as both an operating cash outflow and a financing cash inflow.

As of March 31, 2017, there was approximately $153,700 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 1.75 years. The total deferred tax benefit related to these awards is expected to be approximately $14,184.

The Company has one employee stock option plan under which options may be granted, the 2007 Stock Option and Restricted Stock Plan (the "2007 Plan") approved by the Company’s shareholders at the Company’s Annual Meeting on November 30, 2007. The Board of Directors may grant options to acquire shares of common stock to employees of the Company at the fair market value of the common stock on the date of grant. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2007 Plan, of which 278,300 have been granted and 199,650 are outstanding as of March 31, 2017.

ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for volatility, expected life and interest rates.

The table below outlines the weighted average assumptions that the Company used to calculate the fair value of the option award for the nine months ended March 31, 2017 and 2016, respectively.

	March 31, 2017		March 31, 2016
Dividend yield		3.85%		3.85%
Expected stock price volatility		29.70%		28.09%
Risk-free interest rate		1.84%		1.33%
Expected option life (in years)		4.6 yrs		4.1 yrs
Weighted average fair value per share	$	4.640	$	4.149
of options granted during the period

The Company declares dividends quarterly and paid cash dividends totaling $0.75 for the nine months ended March 31, 2017 and 2016. Our Board of Directors assesses the Company’s dividend policy periodically. There is no assurance that the Board of Directors will maintain the amount of the regular cash dividend. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option life (in years) represents the estimated period of time until exercise and is based on actual historical experience.

The following table summarizes stock option activity during the nine months ended March 31, 2017:

	Employee Stock Options Plan
				Weighted
	Number of			Weighted		Average
	Shares			Average		Remaining		Aggregate
	Subject			Exercise		Contractual		Intrinsic
	To Options			Price		Term		Value
Balance at July 1, 2016		170,450		$	23.84		5.73
Granted		41,150		$	26.25		9.68
Exercised		(8,300	)	$	18.18		—
Forfeited or expired		(3,650	)	$	23.12		—
Outstanding at March 31, 2017		199,650		$	24.59		6.13	$	151,064
Vested or expected to vest at March 31, 2017		188,853		$	24.50		5.96	$	151,064
Exercisable at March 31, 2017		124,950		$	23.66		4.39	$	151,064

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE MKT on March 31, 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on March 31, 2017. This amount changes based on the fair market value of the Company’s common stock. The total intrinsic values of the options exercised during the nine months ended March 31, 2017 and 2016 were $20,769 and $36,374, respectively.

The following table summarizes changes in non-vested stock options during the nine months ended March 31, 2017:

	Weighted Number			Average Grant
	of Shares			Date Fair
	Subject to Option			Value (per Option)
Non-vested at July 1, 2016		45,800		$	4.564
Granted		41,150		$	4.640
Vested		(10,000	)	$	4.296
Forfeited or expired		(2,250	)	$	4.694
Non-vested at March 31, 2017		74,700		$	4.638